HomeGRTX • OTCMKTS
add
Galera Therapeutics Inc
Previous close
$0.026
Day range
$0.021 - $0.025
Year range
$0.015 - $0.060
Market cap
1.50M USD
Avg Volume
29.85K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.44M | -61.65% |
Net income | -1.39M | 75.13% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.43M | 61.73% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.47M | -47.10% |
Total assets | 5.00M | -43.80% |
Total liabilities | 151.65M | -0.21% |
Total equity | -146.64M | — |
Shares outstanding | 75.46M | — |
Price to book | -0.01 | — |
Return on assets | -64.98% | — |
Return on capital | -71.05% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -1.39M | 75.13% |
Cash from operations | -757.00K | 67.06% |
Cash from investing | — | — |
Cash from financing | 0.00 | — |
Net change in cash | -757.00K | 67.00% |
Free cash flow | -266.50K | 87.13% |
About
Founded
2012
Headquarters
Website
Employees
3
